XML 37 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statement of Changes in Stockholders' Equity - USD ($)
Total
Private Placement
Common Stock
Common Stock
Private Placement
Additional Paid - In Capital
Additional Paid - In Capital
Private Placement
Treasury Stock
Deferred Compensation
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2017     16,874,235            
Beginning balance at Dec. 31, 2017 $ 13,123,353   $ 186,299   $ 74,041,083   $ (831,059) $ (7,012,544) $ (53,260,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock (shares)     5,000            
Issuance of common stock 7,911   $ 5   7,906        
Issuance of common stock, employees, restricted (in shares)     175,000            
Issuance of common stock, employees, restricted 0   $ 175   303,575     (303,750)  
Issuance of common stock under equity incentive plan (in shares)     142,112            
Issuance of common stock under equity incentive plan 355,760   $ 142   355,618        
Reversal of deferred compensation amortization that did not vest (in shares)     (66,667)            
Reversal of deferred compensation amortization that did not vest (5,525)   $ (1,060)   (148,540)     144,075  
Warrant compensation cost 8,985       8,985        
Deferred compensation amortization 901,544             901,544  
Purchase of treasury stock (982,487)           (982,487)    
Net (loss) (3,775,815)               (3,775,815)
Ending balance (in shares) at Dec. 31, 2018     17,129,680            
Ending balance at Dec. 31, 2018 9,633,726   $ 185,561   74,568,627   (1,813,546) (6,270,675) (57,036,241)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock (shares)       769,230          
Issuance of common stock   $ 1,793,905   $ 769   $ 1,793,136      
Issuance of common stock, employees, restricted (in shares)     175,000            
Issuance of common stock, employees, restricted 0   $ 175   272,825     (273,000)  
Issuance of common stock under equity incentive plan (in shares)     156,667            
Issuance of common stock under equity incentive plan 398,156   $ 157   397,999        
Reversal of deferred compensation amortization that did not vest (in shares)     (6,000)            
Reversal of deferred compensation amortization that did not vest 0   $ (6)   (13,254)     13,260  
Warrant compensation cost 35,940       35,940        
Deferred compensation amortization 894,261             894,261  
Purchase of treasury stock (71,906)           (71,906)    
Net (loss) (5,115,747)                
Ending balance (in shares) at Dec. 31, 2019     18,224,577            
Ending balance at Dec. 31, 2019 $ 7,568,335   $ 186,656   $ 77,055,273   $ (1,885,452) $ (5,636,154) $ (62,151,988)